| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |